Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
153 Sm-EDTMP and PBSCT for Breast Cancer With Bone Metastases
NCT00429507Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2007
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of samarium-153 lexidronam in breast cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2007; status: completed.
02
Drugs
samarium-153 lexidronam
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00429507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429507.